Pipeline - FluoGuide A/S

English

Pipeline

Our pipeline holds proprietary clinical-stage assets and projects in the preclinical and research phases, all aimed at developing and commercializing applications arising from our unique technology platform.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

Start » Pipeline » Pipeline

Pipeline

FluoGuide’s pipeline is under continuous development, yet focused on aggressive brain cancer and lung cancer. However, FluoGuide technology is widely applicable across multiple cancer types.

Pre-clinical

Phase I

Phase II

Phase III

Commercial

FG001

Aggressive Brain cancer

Info

Next milestone: Consolidated plans

Head and Neck cancer

Info

Next milestone: Consolidated plans

Lung cancer

Info

Next milestone: Consolidated plans

Follow-on pipeline

FG002

Info

Next milestone: CTA submission

Photothermal therapy

Info

Next milestone: Plans and timelines

Completed

Ongoing